0001104659-26-005001.txt : 20260120 0001104659-26-005001.hdr.sgml : 20260120 20260120153311 ACCESSION NUMBER: 0001104659-26-005001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20260120 DATE AS OF CHANGE: 20260120 EFFECTIVENESS DATE: 20260120 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ishara Biotech Fund LP CENTRAL INDEX KEY: 0002052609 ORGANIZATION NAME: EIN: 933190128 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-535668 FILM NUMBER: 26542641 BUSINESS ADDRESS: STREET 1: 4412 ROMERO DRIVE CITY: TARZANA STATE: CA ZIP: 91356 BUSINESS PHONE: (818) 983-4448 MAIL ADDRESS: STREET 1: 4412 ROMERO DRIVE CITY: TARZANA STATE: CA ZIP: 91356 D/A 1 primary_doc.xml X0708 D/A LIVE 0002052609 Ishara Biotech Fund LP 8929 EXPOSITION BOULEVARD LOS ANGELES CA CALIFORNIA 90034 (818) 983-4448 DELAWARE None None Limited Partnership true 2023 N/A Ishara Partners GP, LLC 8929 Exposition Boulevard Los Angeles CA CALIFORNIA 90034 Executive Officer General Partner of the Issuer N/A Ishara Investments LP 8929 Exposition Boulevard Los Angeles CA CALIFORNIA 90034 Executive Officer Investment Manager to the Issuer Shaun Ravi Mehra 8929 Exposition Boulevard Los Angeles CA CALIFORNIA 90034 Executive Officer Portfolio Manager Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.1 true 0001104659-25-004437 2025-01-02 true true false 0 Indefinite 8491000 Indefinite false 11 0 0 0 true The Investment Manager to the Issuer receives a management fee from the Issuer as compensation for its services to the Issuer. false Ishara Biotech Fund LP /s/ Seth Berman Seth Berman CFO and CCO of Investment Manager to the Issuer 2026-01-20